Tumor angiogenesis targeting using imaging agents

Quarterly Journal of Nuclear Medicine

Volumn 45, Issue 2, 2001, Pages 179-182

  Weber, W A ^a   Haubner, R ^a   Vabuliene, E ^a   Kuhnast, B ^a   Wester, H J ^a   Schwaiger, M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Angiogenesis inhibitors; Magnetic resonance imaging; Radionuclide imaging; Tomography, emission computed; Ultrasonography

Indexed keywords

ANGIOGENESIS INHIBITOR; ANNEXIN; ANTINEOPLASTIC AGENT; COPPER DIACETYL BIS(N4 METHYLTHIOSEMICARBAZONE); FLUORINE 18; FLUORODEOXYTHYMIDINE F 18; INDIUM 111; INTEGRIN; IODINE 123; MISONIDAZOLE; PENTAPEPTIDE; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

APOPTOSIS; BIOLOGICAL MONITORING; BLOOD VESSEL PERMEABILITY; CANCER; CANCER GROWTH; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL METABOLISM; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CYTOSTASIS; CYTOTOXICITY; DIAGNOSTIC IMAGING; DOPPLER ECHOGRAPHY; DRUG EFFICACY; DRUG MECHANISM; DRUG PROTEIN BINDING; HEALTH CARE COST; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR BIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROTEIN TARGETING; SCINTIGRAPHY; SCINTISCANNING; TUMOR VASCULARIZATION;

ANGIOGENESIS INHIBITORS; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034942982     PISSN: 11243937     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Mechanisms of angiogenesis and arteriogenesis
2. Vascular-specific growth factors and blood vessel formation
3. Tumor angiogenesis - New drugs on the block
4. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
5. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: Standardized quantities and symbols
6. Evaluation of tumor angiogenesis with US: Imaging, Doppler, and contrast agents
7. Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: A rapid and noninvasive dynamic method
8. Nitroimidazoles and imaging hypoxia
9. Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model
10. Neoadjuvant therapy of esophageal squamous cell carcinoma: Response evaluation by positron emission tomography
11. Apoptotic cell death: Its implications for imaging in the next millennium
12. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography
13. N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists
14. Glycosylated RGD-containing peptides: Tracer for tumor targeting and angiogenesis imaging with improved biokinetics
15. Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy
16. Non-invasive imaging of αvβ3 integrin expression using a 18F-labeled RGD-containing glycopeptide and positron emission tomography